INVITRO EFFECTS OF FOLATE INHIBITORS ON TOXOPLASMA-GONDII

被引：73

作者：

DEROUIN, F ^{[1
]}

CHASTANG, C ^{[1
]}

机构：

[1] HOP ST LOUIS,DEPT BIOSTAT & INFORMAT MED,F-75475 PARIS 10,FRANCE

来源：

关键词：

D O I：

10.1128/AAC.33.10.1753

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页码：1753 / 1759

页数：7

共 27 条

[21] BIOAVAILABILITY OF ORAL TRIMETREXATE IN PATIENTS WITH ACQUIRED IMMUNODEFICIENCY SYNDROME
ROGERS, P
ALLEGRA, CJ
MURPHY, RF
DRAKE, JC
MASUR, H
POPLACK, DG
CHABNER, BA
PARRILLO, JE
LANE, HC
BALIS, FM
[J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) : 324 - 326
[22] Sabin AB, 1942, P SOC EXP BIOL MED, V51, P19, DOI 10.3181/00379727-51-13809
[23] Scheffe H., 1999, ANAL VARIANCE, V72
[24] EFFECT OF PYRIMETHAMINE AND SULFADIAZINE ON FINE-STRUCTURE AND MULTIPLICATION OF TOXOPLASMA-GONDII IN CELL-CULTURES
SHEFFIELD, HG
MELTON, ML
[J]. JOURNAL OF PARASITOLOGY, 1975, 61 (04) : 704 - 712
[25] WEIDEKAMM E, 1982, B WORLD HEALTH ORGAN, V60, P115
[26] PYRIMETHAMINE CONCENTRATIONS IN SERUM AND CEREBROSPINAL-FLUID DURING TREATMENT OF ACUTE TOXOPLASMA ENCEPHALITIS IN PATIENTS WITH AIDS
WEISS, LM
HARRIS, C
BERGER, M
TANOWITZ, HB
WITTNER, M
[J]. JOURNAL OF INFECTIOUS DISEASES, 1988, 157 (03) : 580 - 583
[27] ZINNER SH, 1985, PRINCIPLES PRACTICE, P237